GlassScriptPhysician profile
Elaine Rosaci
NPI 1578206199
$771.97
in general payments reported to CMS, 2019-2025
15 companies · $287 in 2025
The $287 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $485 · 2025: $287.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $772.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $771.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $143.34 | 2024-2025 | Ozempic, Rybelsus |
| Abiomed | $125.00 | 2024 | Impella |
| Astrazeneca Pharmaceuticals LP | $116.29 | 2024-2025 | Farxiga, Breztri |
| Glaxosmithkline, LLC. | $50.83 | 2024-2025 | Arexvy, Trelegy Ellipta |
| Amgen INC. | $50.57 | 2024-2025 | Evenity, Prolia, Repatha |
| Pfizer INC. | $49.21 | 2024-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $43.20 | 2024 | |
| Lilly USA, LLC | $42.67 | 2024 | Jardiance, Mounjaro |
| Boehringer Ingelheim Pharmaceuticals, INC. | $35.11 | 2024 | Jardiance, Synjardy |
| Exact Sciences Corporation | $23.39 | 2024 | Cologuard Collection Kit |
| Medtronic, INC. | $20.74 | 2025 | Intellis Adaptivestim |
| Photonicare INC | $19.90 | 2025 | Otosight Middle Ear Scope |
| Paratek Pharmaceuticals, INC. | $18.20 | 2025 | Nuzyra |
| Merck Sharp & Dohme LLC | $17.48 | 2025 | Capvaxive |
| Abbvie INC. | $16.04 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elaine Rosaci listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.